Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Medical Industry Today.
Press releases published on June 5, 2025
Tonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025
GlobeNewswire
·
June 5, 2025
CHATHAM, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with marketed products and a pipeline of development candidates, today announced a poster …
Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
GlobeNewswire
·
June 5, 2025
– KPL-387 Phase 2/3 trial on track to initiate in mid-2025; Phase 2 data expected in 2H 2026 – – KPL-387 Phase 1 single ascending dose data support profile for monthly dosing – – Presentation and webcast at Jefferies 2025 Global Healthcare Conference …
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
GlobeNewswire
·
June 5, 2025
TORONTO, June 05, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm"), a pharmaceutical company specialized in precision-based cannabinoids, announced the closing of the sale of its Hope, British Columbia …
Attention Craft Beer Fans! Tilray Beverages Highlights Boldest Brews For Summer
GlobeNewswire
·
June 5, 2025
ATLANTA, June 05, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is turning up the heat this summer with a …
Upstream Bio to Present Mechanistic Insights into Verekitug’s Enhanced Potency via TSLP Receptor Targeting at European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025
GlobeNewswire
·
June 5, 2025
WALTHAM, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced an upcoming presentation at …
Savage, MN Gets Expanded Access to Premium Physical Therapy as Family Physical Therapy Relocates to Larger Facility
GlobeNewswire
·
June 5, 2025
TWIN CITIES, Minn., June 05, 2025 (GLOBE NEWSWIRE) -- Family Physical Therapy of Savage, MN is excited to announce our relocation to the former Finish Line Wellness space! As a premium healthcare facility, we now offer direct access physical therapy. This …
Avricore Appoints Rodger Seccombe as CEO
GlobeNewswire
·
June 5, 2025
VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “Avricore”) is pleased to report the appointment of Rodger Seccombe as CEO of the Company. Mr. Seccombe currently serves as Chief Technology …
Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo’s Canadian Portfolio
GlobeNewswire
·
June 5, 2025
MONTREAL and MARLBOROUGH, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, and Sumitomo Pharma America Inc. (“SMPA”) announced today that Knight and SMPA’s …
Thérapeutique Knight et Sumitomo Pharma signent des ententes exclusives de licence de commercialisation du portefeuille canadien de Sumitomo
GlobeNewswire
·
June 5, 2025
MONTRÉAL et MARLBOROUGH, Mass., 05 juin 2025 (GLOBE NEWSWIRE) -- Thérapeutique Knight inc. (TSX : GUD) (« Knight »), société pharmaceutique spécialisée panaméricaine (hors États-Unis), et Sumitomo Pharma America Inc. (« SMPA ») ont annoncé aujourd’hui que …
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
GlobeNewswire
·
June 5, 2025
PORTLAND, Maine, June 05, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people
GlobeNewswire
·
June 5, 2025
In 2024, Philips Foundation initiated 22 new projects and 5 new impact investments expanding its impact and reach in innovative healthcare delivery to India and South America Celebrating a decade of impact with strong progress towards the Foundation’s 2030 …
MUSE Microscopy, Inc. Welcomes Dr. Derek C. Welch to Board of Directors, Appoints Him Chair of Science & Technology Committee
GlobeNewswire
·
June 5, 2025
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, proudly announces the appointment of Dr. Derek C. Welch, MD, FCAP, to its Board of Directors. Dr. Welch, the President and Chief Medical …
Cutest Pets on Parliament Hill 2025: Winners Unveiled at Purr-fectly Playful Pet Gala
GlobeNewswire
·
June 5, 2025
OTTAWA, Ontario, June 05, 2025 (GLOBE NEWSWIRE) -- It was paws-itively unforgettable at the 3rd Annual Cutest Pets on Parliament Hill awards celebration, where the winning pets of 2025 were officially crowned at a lively, pet-themed gala hosted by the …
Les animaux de compagnie les plus mignons sur la Colline du Parlement 2025 : Les gagnants sont dévoilés lors d’un gala où les vedettes portaient de riches fourrures
GlobeNewswire
·
June 5, 2025
OTTAWA, Ontario, 05 juin 2025 (GLOBE NEWSWIRE) -- La troisième cérémonie annuelle de remise des prix pour le concours « Les animaux de compagnie les plus mignons sur la Colline du Parlement » a été mémorable. Les gagnants de 2025 ont été officiellement …
Osivax Announces Last Patient Last Visit in Phase 2a Trial Evaluating a Booster Dose of Broad-Spectrum Influenza Vaccine OVX836 s release
GlobeNewswire
·
June 5, 2025
Final results expected in H2 2025 Lyon, France – June 5, 2025 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, today announced that all participants have completed …
Projet de loi 103 : l’ASPQ plaide pour des décisions éclairées, fondées sur les faits et le dialogue
GlobeNewswire
·
June 5, 2025
MONTRÉAL, June 05, 2025 (GLOBE NEWSWIRE) -- Alors que les consultations publiques sur le projet de loi 103 visant l’encadrement des sites de consommation supervisée (SCS) viennent de se conclure, l’Association pour la santé publique du Québec (ASPQ) …
Merus N.V. gibt geplantes öffentliches Zeichnungsangebot von Stammaktien bekannt
GlobeNewswire
·
June 5, 2025
UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts, June 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) („Merus“, das „Unternehmen“, „wir“ und „unser“), ein Onkologieunternehmen, das innovative, multispezifische Antikörper in voller Länge und …
Merus N.V. annonce une offre publique de souscription d’actions ordinaires
GlobeNewswire
·
June 5, 2025
UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », la « Société », « nous » et « notre »), une société spécialisée dans l’oncologie qui développe des anticorps multispécifiques innovants …
Oculis Publishes Results of 2025 Annual General Meeting
GlobeNewswire
·
June 5, 2025
ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2025 Annual General Meeting held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11, CH-6300 Zug, …
Press release: Sanofi Launches 2025 Global Employee Stock Purchase Plan
GlobeNewswire
·
June 5, 2025
Sanofi Launches 2025 Global Employee Stock Purchase Plan Paris, June 5, 2025. Sanofi’s global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries. Now in its 11th year, the program demonstrates the …